Details for Patent: 8,911,786
✉ Email this page to a colleague
Which drugs does patent 8,911,786 protect, and when does it expire?
Patent 8,911,786 protects FYARRO and is included in one NDA.
This patent has sixty-eight patent family members in twenty-three countries.
Summary for Patent: 8,911,786
| Title: | Nanoparticle comprising rapamycin and albumin as anticancer agent |
| Abstract: | The present invention features methods for treating, stabilizing, preventing, and/or delaying cancer by administering nanoparticles that comprise rapamycin or a derivative thereof. The invention also provides compositions (e.g., unit dosage forms) comprising nanoparticles that comprise a carrier protein and rapamycin or a derivative thereof. The invention further provides combination therapy methods of treating cancer comprising administering to an individual an effective amount of nanoparticles that comprise rapamycin or a derivative thereof and a second therapy. |
| Inventor(s): | Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA), Trieu; Vuong (Calabasas, CA) |
| Assignee: | Abraxis Bioscience, LLC (Los Angeles, CA) |
| Application Number: | 12/530,188 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Device; Dosage form; |
Drugs Protected by US Patent 8,911,786
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMOR (PECOMA) | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,911,786
| PCT Information | |||
| PCT Filed | March 07, 2008 | PCT Application Number: | PCT/US2008/003096 |
| PCT Publication Date: | September 12, 2008 | PCT Publication Number: | WO2008/109163 |
International Family Members for US Patent 8,911,786
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008223334 | ⤷ Sign Up | |||
| Brazil | PI0808635 | ⤷ Sign Up | |||
| Canada | 2680207 | ⤷ Sign Up | |||
| Canada | 3006137 | ⤷ Sign Up | |||
| Canada | 3201293 | ⤷ Sign Up | |||
| China | 101730526 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
